Skip to main content

Table 2 Multivariate analyses

From: Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity

  

OS

  

PFS

  

Parameter

Reference

p value

HR

95% confidence interval

p value

HR

95% confidence interval

T-stage

       

T3/4

T1/2

0.633

0.8

0.3–2.1

0.454

0.7

0.3–1.8

T2 + 1

T1/2

0.388

0.6

0.2–1.9

0.346

0.6

0.2–1.8

Chemotherapy

No chemotherapy

0.017

0.4

0.2–0.8

0.070

0.5

0.2–1.1

Charlson index

No comorbidities

0.897

1.1

0.5–2.5

0.647

1.2

0.5–2.8

Age

 

0.060

1.0

1.0–1.1

0.049

1.1

1.0–1.1

BMI

       

Underweight

Normal weight

0.062

2.5

1.0–6.7

0.004

3.9

1.5–9.8

Overweight

 

0.426

1.3

0.7–2.5

0.530

1.2

0.6–2.4

Obese

 

0.978

1.0

0.4–2.2

0.680

1.2

0.5–2.7

  1. 1T2 + was used for tumors stages at least T2 but without further exact T-staging
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us